March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Elvina Almuradova: 177 Lu-edotreotide vs everolimus in GEP-NETs
Mar 11, 2025, 07:33

Elvina Almuradova: 177 Lu-edotreotide vs everolimus in GEP-NETs

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on LinkedIn:

“The Phase 3 COMPETE trial shows 177Lu-edotreotide significantly improves PFS vs everolimus in GEP-NETs.

  • 23.9 vs 14.1 months; HR 0.67
  • TEAEs: 82.5% vs 97%

A major step forward!”